Your browser doesn't support javascript.
loading
Variants in the fetal genome near FLT1 are associated with risk of preeclampsia.
McGinnis, Ralph; Steinthorsdottir, Valgerdur; Williams, Nicholas O; Thorleifsson, Gudmar; Shooter, Scott; Hjartardottir, Sigrun; Bumpstead, Suzannah; Stefansdottir, Lilja; Hildyard, Lucy; Sigurdsson, Jon K; Kemp, John P; Silva, Gabriela B; Thomsen, Liv Cecilie V; Jääskeläinen, Tiina; Kajantie, Eero; Chappell, Sally; Kalsheker, Noor; Moffett, Ashley; Hiby, Susan; Lee, Wai Kwong; Padmanabhan, Sandosh; Simpson, Nigel A B; Dolby, Vivien A; Staines-Urias, Eleonora; Engel, Stephanie M; Haugan, Anita; Trogstad, Lill; Svyatova, Gulnara; Zakhidova, Nodira; Najmutdinova, Dilbar; Dominiczak, Anna F; Gjessing, Håkon K; Casas, Juan P; Dudbridge, Frank; Walker, James J; Pipkin, Fiona Broughton; Thorsteinsdottir, Unnur; Geirsson, Reynir T; Lawlor, Debbie A; Iversen, Ann-Charlotte; Magnus, Per; Laivuori, Hannele; Stefansson, Kari; Morgan, Linda.
Afiliación
  • McGinnis R; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Steinthorsdottir V; deCODE Genetics/Amgen, Reykjavik, Iceland.
  • Williams NO; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Thorleifsson G; deCODE Genetics/Amgen, Reykjavik, Iceland.
  • Shooter S; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Hjartardottir S; Department of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, Iceland.
  • Bumpstead S; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Stefansdottir L; deCODE Genetics/Amgen, Reykjavik, Iceland.
  • Hildyard L; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Sigurdsson JK; deCODE Genetics/Amgen, Reykjavik, Iceland.
  • Kemp JP; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
  • Silva GB; University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.
  • Thomsen LCV; Centre of Molecular Inflammation Research (CEMIR) and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Jääskeläinen T; St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Kajantie E; Centre of Molecular Inflammation Research (CEMIR) and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Chappell S; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
  • Kalsheker N; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Moffett A; National Institute for Health and Welfare, Helsinki, Finland.
  • Hiby S; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lee WK; PEDEGO Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Padmanabhan S; School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Simpson NAB; School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Dolby VA; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Staines-Urias E; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Engel SM; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Haugan A; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Trogstad L; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.
  • Svyatova G; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.
  • Zakhidova N; Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Najmutdinova D; Nuffield Department of Obstetrics &Gynaecology, University of Oxford, Oxford, UK.
  • Dominiczak AF; Norwegian Institute of Public Health, Oslo, Norway.
  • Gjessing HK; Scientific Center of Obstetrics, Gynecology and Perinatology, Almaty, Kazakhstan.
  • Casas JP; Institute of Immunology, Uzbek Academy of Sciences, Tashkent, Uzbekistan.
  • Dudbridge F; Republic Specialized Scientific Practical Medical Centre of Obstetrics and Gynecology, Tashkent, Uzbekistan.
  • Thorsteinsdottir U; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Geirsson RT; Norwegian Institute of Public Health, Oslo, Norway.
  • Lawlor DA; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Iversen AC; Farr Institute of Health Informatics, University College London, London, UK.
  • Magnus P; Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Laivuori H; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.
  • Stefansson K; Medical School, University of Nottingham, Nottingham, UK.
  • Morgan L; deCODE Genetics/Amgen, Reykjavik, Iceland.
Nat Genet ; 49(8): 1255-1260, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28628106
ABSTRACT
Preeclampsia, which affects approximately 5% of pregnancies, is a leading cause of maternal and perinatal death. The causes of preeclampsia remain unclear, but there is evidence for inherited susceptibility. Genome-wide association studies (GWAS) have not identified maternal sequence variants of genome-wide significance that replicate in independent data sets. We report the first GWAS of offspring from preeclamptic pregnancies and discovery of the first genome-wide significant susceptibility locus (rs4769613; P = 5.4 × 10-11) in 4,380 cases and 310,238 controls. This locus is near the FLT1 gene encoding Fms-like tyrosine kinase 1, providing biological support, as a placental isoform of this protein (sFlt-1) is implicated in the pathology of preeclampsia. The association was strongest in offspring from pregnancies in which preeclampsia developed during late gestation and offspring birth weights exceeded the tenth centile. An additional nearby variant, rs12050029, associated with preeclampsia independently of rs4769613. The newly discovered locus may enhance understanding of the pathophysiology of preeclampsia and its subtypes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Preeclampsia / Predisposición Genética a la Enfermedad / Receptor 1 de Factores de Crecimiento Endotelial Vascular / Feto Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Pregnancy Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Asunto principal: Preeclampsia / Predisposición Genética a la Enfermedad / Receptor 1 de Factores de Crecimiento Endotelial Vascular / Feto Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Pregnancy Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido